Form F-3 - Registration statement by foreign private issuers:
SEC Accession No. 0001193125-18-298482
Filing Date
2018-10-12
Accepted
2018-10-12 17:24:15
Documents
7

Document Format Files

Seq Description Document Type Size
1 F-3 d634167df3.htm F-3 383449
2 EX-1.2 d634167dex12.htm EX-1.2 196329
3 EX-5.1 d634167dex51.htm EX-5.1 27776
4 EX-23.1 d634167dex231.htm EX-23.1 3951
5 GRAPHIC g634167g80y42.jpg GRAPHIC 2412
6 GRAPHIC g634167g84s08.jpg GRAPHIC 10021
7 GRAPHIC g634167g97n85.jpg GRAPHIC 4691
  Complete submission text file 0001193125-18-298482.txt   636424
Mailing Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007
Business Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007 972 9 770 7601
UroGen Pharma Ltd. (Filer) CIK: 0001668243 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: F-3 | Act: 33 | File No.: 333-227811 | Film No.: 181120851
SIC: 2834 Pharmaceutical Preparations